173 related articles for article (PubMed ID: 27647473)
1. In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.
Massari CM; Castro AA; Dal-Cim T; Lanznaster D; Tasca CI
Toxicol In Vitro; 2016 Dec; 37():162-168. PubMed ID: 27647473
[TBL] [Abstract][Full Text] [Related]
2. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
Marques NF; Massari CM; Tasca CI
Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices.
Ludka FK; Dal-Cim T; Binder LB; Constantino LC; Massari C; Tasca CI
Mol Neurobiol; 2017 Jul; 54(5):3149-3161. PubMed ID: 27052955
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.
Prajapati SK; Garabadu D; Krishnamurthy S
Neurotox Res; 2017 May; 31(4):478-492. PubMed ID: 28130746
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A
Massari CM; Constantino LC; Tasca CI
Purinergic Signal; 2021 Jun; 17(2):247-254. PubMed ID: 33548045
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
8. MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Srivastava N; Shukla S
ACS Chem Neurosci; 2017 Mar; 8(3):592-605. PubMed ID: 27977132
[TBL] [Abstract][Full Text] [Related]
9. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.
Cunha MP; Martín-de-Saavedra MD; Romero A; Egea J; Ludka FK; Tasca CI; Farina M; Rodrigues AL; López MG
ASN Neuro; 2014; 6(6):. PubMed ID: 25424428
[TBL] [Abstract][Full Text] [Related]
10. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease.
Vorobyov VV; Schibaev NV; Morelli M; Carta AR
Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
12. Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
Marques NF; Binder LB; Roversi K; Sampaio TB; Constantino LC; Prediger RD; Tasca CI
Behav Brain Res; 2019 Oct; 372():112014. PubMed ID: 31212060
[TBL] [Abstract][Full Text] [Related]
13. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease.
Filomeni G; Graziani I; De Zio D; Dini L; Centonze D; Rotilio G; Ciriolo MR
Neurobiol Aging; 2012 Apr; 33(4):767-85. PubMed ID: 20594614
[TBL] [Abstract][Full Text] [Related]
15. 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat.
Gonçalves DF; Courtes AA; Hartmann DD; da Rosa PC; Oliveira DM; Soares FAA; Dalla Corte CL
Neurotoxicology; 2019 Jan; 70():1-11. PubMed ID: 30359634
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.
Vorobyov V; Sengpiel F
Exp Brain Res; 2008 Nov; 191(3):277-87. PubMed ID: 18682921
[TBL] [Abstract][Full Text] [Related]
19. Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
Manouchehrabadi M; Farhadi M; Azizi Z; Torkaman-Boutorabi A
Neurotox Res; 2020 Jan; 37(1):156-170. PubMed ID: 31364033
[TBL] [Abstract][Full Text] [Related]
20. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
Robinson S; Krentz L; Moore C; Meshul CK
Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
